NIH Opened Its $8 Million Construction Grants to For-Profit Companies, Then Rescinded the Notice Five Days Later. The Trade Press Never Caught the Reversal.

On September 11, 2026, NIH published NOT-OD-26-089, a notice of change to eligible organizations for PAR-26-106, the C06 construction grant program that funds shared-use biomedical research facilities. The change was substantial: for application due dates on or after January 25, 2027, eligibility would expand from colleges, universities, and nonprofits to include for-profit organizations, small businesses, state and local governments, tribal governments, independent school districts, faith-based organizations, and community groups. Awards run to $8 million. Trade publications covered it as a significant opening of federal research construction money to industry.

On September 16, 2026 — five days later — NIH rescinded the notice.

The revised PAR-26-106 full announcement now in circulation lists the original eligibility set and nothing more: higher education institutions of all types, public and state-controlled institutions of higher education, private institutions of higher education, nonprofits other than institutions of higher education, nonprofits with 501(c)(3) IRS status, and nonprofits without 501(c)(3) status. For-profit organizations and small businesses are not listed as eligible. Several secondary sources and aggregators are still publishing the expansion as current fact, including outlets that correctly reported the September 11 notice and never revisited it.

If you are a small business or a for-profit research organization that read the September coverage and began assembling a C06 application for the January 25, 2027 due date, stop and verify eligibility directly in the announcement before spending another hour. That is the practical headline. The rest of this is why the program is worth understanding anyway, because the January date is live, the money is real, and the field is narrower than most eligible institutions realize.

What PAR-26-106 Actually Funds

The announcement title is "Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)," released March 6, 2026, administered by the NIH Office of Research Infrastructure Programs. It consolidates two long-running construction programs:

• Biomedical Research Facilities (BRF), with award budgets from $2,000,000 to $8,000,000.
• HIV/AIDS Research Facilities (HRF), with award budgets from $2,000,000 to $4,000,000.

The program funds construction and modernization of shared-use research facilities or research-supporting facilities that serve broad research communities rather than a single investigator. Across the FY2026 cycle NIH signaled roughly $88 million available with up to 14 awards anticipated, though as with every C06 cycle the figures are contingent on appropriations and application volume.

Cost sharing is not required, which is unusual for federal construction money and makes C06 meaningfully more accessible than most facilities programs.

Due dates recur on a quarterly rhythm through the announcement's life: July 2026, October 2026, December 2026, January 25, 2027, then June 2027, October 2027, December 2027, January 25, 2028, and continuing into 2028. The announcement expires January 26, 2028. Review for a January 25, 2027 submission runs scientific merit review in June 2027, advisory council in October 2027, and earliest project start in December 2027 — a 23-month gap between submission and first spending that construction planners need to build into their capital timelines.

The 25 Percent Set-Aside Most Applicants Ignore

At least 25 percent of funds appropriated to the BRF program are reserved for Institutions of Emerging Excellence. On an $80 million BRF budget that is $20 million carved out of the competitive pool before established research universities compete for the remainder.

IEE, as the announcement frames it, covers institutions demonstrating emerging excellence in biomedical or behavioral research that are located in areas with significant public health challenges and are actively addressing the health deficits of the populations they serve. That definition is doing real work. It is not a Carnegie classification or a research-expenditure threshold; it combines research trajectory with geographic and population-health context.

For an institution that fits, the arithmetic is favorable in a way few NIH competitions are. A $20 million set-aside against awards of $2 million to $8 million implies a handful of awards drawn from a self-selected and much smaller applicant pool. For institutions that do not fit, the honest read is that the general BRF pool is smaller than the topline number suggests, and an application should be scoped accordingly.

The failure mode here is institutions that plausibly qualify as IEE but do not make the case in the application, because they think of themselves primarily as research institutions rather than as institutions serving a population with documented health deficits. The documentation is not difficult — county health rankings, service-area demographics, disease burden data — but it has to be present.

The Commitments That Outlast the Grant

C06 carries post-award obligations that dwarf the typical grant closeout, and they are the reason some eligible institutions should not apply.

The funded facility must be used for biomedical research for at least 10 years from beneficial occupancy, and the institution must certify compliance annually for 20 years after completion. Two decades of annual certification on a building is a governance commitment, not a reporting one. It survives leadership turnover, strategic plan rewrites, and campus master plan revisions. An institution that might want to convert the space to clinical or instructional use in year eight is accepting a constraint it cannot easily unwind.

The unallowable cost list is equally structural:

• Facilities and administrative costs are not recoverable. There is no indirect cost on a C06.
• Scientific instruments and non-fixed equipment are excluded. C06 pays for the building and its fixed systems; the instruments that make it a research facility come from somewhere else.
• Personnel costs unrelated to construction, and bonus payments, are out.
• Supplies, interior and exterior decorating, parking construction, and landscaping are out.
• Billable medical or office space projects are out.

Taken together: C06 is a shell-and-fixed-systems program with no overhead recovery and no equipment. An institution needs a parallel funding path for instrumentation — an S10 instrumentation grant, an S15 shared-use equipment award, state capital funds, or philanthropy — and the application is stronger when that path is specified rather than implied. Reviewers assessing whether a facility will actually function as described are reading for exactly that.

Why the Rescission Probably Happened, and What It Signals

NIH did not state a reason, and the rescinded notice itself contains no rationale or replacement reference. Any explanation is inference, but the shape of the problem is visible.

The C06 statutory and policy framework is built around nonprofit stewardship of federally funded research space. The 10-year use requirement and 20-year certification regime assume an institution whose mission is durable and whose property is not an asset that can be sold, collateralized, or repurposed by acquisition. Extending eligibility to for-profit entities raises questions the existing terms do not answer: what happens to a federally funded facility when the company that owns it is acquired in year six, or liquidated in year nine? What prevents a taxpayer-funded building from appearing on a balance sheet as collateral? The absence of a cost-share requirement, benign for a university, becomes a harder sell when the recipient has equity investors.

A five-day turnaround suggests the notice cleared without full policy review and that someone identified a genuine conflict rather than a political one. Notably, the expansion as drafted would also have applied to state and local governments and tribal governments — categories where the stewardship objection is far weaker. That those were rescinded along with for-profits points to a wholesale pullback for re-drafting rather than a targeted reversal.

Whether a narrower expansion returns is worth watching. It would not be surprising to see a future notice admit governmental and tribal applicants with the for-profit category left out or conditioned on cost share and a reversionary interest. For now, the operative document is the revised announcement, and it is nonprofit and academic only.

Strategy

Verify eligibility in the announcement itself, every time. This episode is a clean illustration of why the Guide notice stream is not a reliable standalone source. A notice can be rescinded in under a week while coverage of it persists indefinitely. The authoritative eligibility list is the current full announcement for the due date you are targeting — not a notice, not an aggregator listing, not a news article. Institutions tracking NIH policy through secondary digests should treat this as a prompt to add a verification step.

If you are an eligible academic or nonprofit institution, the January 25, 2027 date is the near cycle. Working backward from a 23-month submission-to-start timeline, the construction documents, site control, and institutional capital commitment all need to be in place now. C06 applications fail more often on construction readiness than on scientific merit.

Assess your IEE standing honestly and early. The 25 percent set-aside is the single largest structural advantage available in this program, and it requires affirmative documentation of both research trajectory and service-area health burden. If your institution may qualify, that case belongs in the first draft, not a late addition.

Budget the gaps the program will not cover. No F&A, no instruments, no non-fixed equipment. A credible application names the funding source for each of those and shows that the facility reaches operational capability without additional C06 money.

If you are a for-profit research organization: the door opened on September 11 and closed on September 16. The strategic response is not to apply anyway but to comment and engage when a revised expansion surfaces — and in the interim, to pursue facility capacity through partnership with an eligible academic host, where shared-use is the program's stated purpose and a company-sponsored core facility inside a university is a structure C06 already contemplates.

NIH's FY2026 research infrastructure spending has been unusually active, from the facilities construction tied to human-based research methods to the fully obligated FY2026 award cycle. The C06 program is a small line inside that, and for an institution with a shovel-ready shared-use facility and no cost-share capacity, it is one of the few federal construction vehicles that still works. Just read the eligibility list in the announcement, not in the news.